Literature DB >> 3274314

Comparative pharmacokinetics of cyclosporine and NVa2-cyclosporine in dogs.

R Venkataramanan1, S Todo, I Zaghloul, S Lynch, I Kam, R J Ptachcinski, G J Burckart, T E Starzl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3274314      PMCID： PMC2911137     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  5 in total

1.  Cyclosporine G Analysis and Monitoring by High-Pressure Liquid Chromatography.

Authors:  I Zaghloul; G J Burckart; T E Starzl; S Todo; R J Ptachcinski; R Venkataramanan
Journal:  Transplant Proc       Date:  1986-08       Impact factor: 1.066

2.  Cyclosporin G: immunosuppressive effect in dogs with renal allografts.

Authors:  R Y Calne; D J White; S Thiru; K Rolles; S Drakopoulos; N V Jamieson
Journal:  Lancet       Date:  1985-06-08       Impact factor: 79.321

3.  Comparison of the pharmacological profiles of cyclosporine, (Nva2)-cyclosporine and (Val2)dihydro-cyclosporine.

Authors:  P C Hiestand; H C Gunn; J M Gale; B Ryffel; J F Borel
Journal:  Immunology       Date:  1985-06       Impact factor: 7.397

4.  Cyclosporine kinetics in renal transplantation.

Authors:  R J Ptachcinski; R Venkataramanan; J T Rosenthal; G J Burckart; R J Taylor; T R Hakala
Journal:  Clin Pharmacol Ther       Date:  1985-09       Impact factor: 6.875

5.  Canine liver transplantation under Nva2-cyclosporine versus cyclosporine.

Authors:  S Todo; K A Porter; I Kam; S Lynch; R Venkataramanan; A DeWolf; T E Starzl
Journal:  Transplantation       Date:  1986-03       Impact factor: 4.939
  5 in total
  1 in total

1.  Pharmacokinetics of the cyclosporine-ketoconazole interaction in dogs.

Authors:  A D'mello; R Venkataramanan; M Satake; S Todo; S Takaya; R J Ptachcinski; G J Burckart; T E Starzl
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1989-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.